STAT

Gawande says health venture is not seeking profits. But whose bottom line will it benefit?

Dr. Atul Gawande has described his new health care company as a “nonprofit” that will operate independently from the three massive corporations providing its funding — a firewall he said is crucial to ensuring its mission stays focused on the needs of patients.

But since he was named CEO in June, the three founders of the company — Amazon, JPMorgan Chase, and Berkshire Hathaway — have remained circumspect about the health venture’s precise legal structure, focus, and funding.

A person familiar with the inner-workings of the enterprise told STAT that its corporate creators

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

Related Books & Audiobooks